軟骨変性の世界市場レポート 2025年

軟骨変性の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.5％で166億2,000万米ドルに成長します。予測期間の成長は、再生医療の進歩、生物学的注射、組織工学ソリューション、精密医療、ロボット支援手術に起因しています。予測期間における主な動向としては、幹細胞治療、整形外科における3Dプリンティング、軟骨修復のための遺伝子治療、個別化リハビリテーションプログラム、経過観察のための遠隔医療などが挙げられます。

肥満の増加は、今後数年間の軟骨変性市場の成長を牽引すると予想されます。肥満は体脂肪の過剰蓄積を特徴とする病態であり、重大な健康リスクをもたらします。肥満は、軟骨への圧縮力を増大させ、炎症性サイトカインを促進することにより、軟骨変性に寄与します。この状態は、異常な関節負荷、関節の不正配列、筋力低下など、膝関節のいくつかの病理学的変化を引き起こします。例えば、英国の政府デジタルサービスのデータによると、2021～2022年にかけて、18歳以上の成人の63.8％が過体重または肥満に分類され、前年の63.3％から増加したことが明らかになりました。さらに、成人の肥満率は2020-2021年の25.2％から25.9％に増加しました。これらの統計は、肥満の影響が拡大していることを浮き彫りにしており、軟骨変性市場の拡大に拍車をかけています。

軟骨変性市場の成長は、高齢者人口の増加によっても後押しされています。65歳以上の高齢者は筋肉や骨量の減少を経験し、筋力や関節機能の低下につながります。軟骨変性治療は、筋骨格系の加齢による変化を緩和し、骨を強化し、骨量減少を遅らせるという重要な役割を担っています。世界保健機関（WHO）によると、60歳以上の世界人口は2020年の10億人から2030年には14億人、2050年には21億人に増加すると予測されています。さらに、80歳以上の人口は2020年の1億4,300万人から、2050年には3倍の4億2,600万人になると予想されています。この人口動向は、軟骨変性市場の主要促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の軟骨変性市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の軟骨変性市場：成長率分析
• 世界の軟骨変性市場の実績：規模と成長、2019～2024年
• 世界の軟骨変性市場の予測：規模と成長、2024～2029年、2034年
• 世界の軟骨変性総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の軟骨変性市場：手順別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節置換術
• 軟骨形成術
• 骨軟骨移植
• マイクロフラクチャー
• 半月板移植
• 細胞ベースの軟骨表面再生
• 自家軟骨細胞移植
• 世界の軟骨変性市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 膝関節
• 股関節
• その他
• 世界の軟骨変性市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院・専門クリニック
• 外来手術センター
• 学術研究機関
• 世界の軟骨変性市場：関節置換術のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 膝関節置換術（部分的、全的）
• 股関節置換術（部分的、全的）
• 肩関節置換術（全的、逆置換）
• その他の関節（足首、肘、手首）
• 世界の軟骨変性市場：軟骨形成術のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ラジオ波焼灼軟骨形成術
• 機械的軟骨形成術
• 熱軟骨形成術
• 関節鏡下軟骨形成術
• 世界の軟骨変性市場：骨軟骨移植のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 自家移植（OATS）
• 同種移植（新鮮骨軟骨同種移植）
• 合成インプラント
• 世界の軟骨変性市場：マイクロフラクチャーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 従来型マイクロフラクチャー術
• 強化型マイクロフラクチャー術
• 世界の軟骨変性市場：半月板移植のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 同種半月板移植
• 合成半月板インプラント
• 世界の軟骨変性市場：細胞ベースの軟骨再生のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 自家細胞療法
• 同種細胞療法
• 幹細胞を用いた軟骨修復
• 世界の軟骨変性市場：自家軟骨細胞移植（ACI）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 第1世代ACI
• 第2世代ACI
• 第3世代ACI（MACI）
• 世界の軟骨変性市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節鏡によるデブリードマン
• 骨切り術
• 合成スキャフォールドを用いた軟骨修復
• 注射による治療法

第7章 地域別・国別分析

• 世界の軟骨変性市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の軟骨変性市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 軟骨変性市場：競合情勢
• 軟骨変性市場：企業プロファイル
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • MEDIPOST Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Smith and Nephew plc
• B Braun Melsungen AG
• Osiris Therapeutics Inc.
• Arthrex Inc.
• Conmed Corporation
• Orthocell Ltd.
• Bioventus LLC
• Aesculap Inc.
• Vericel Corporation
• Anika Therapeutics Inc.
• Geistlich Pharma AG
• MatTek Corporation
• Breg Inc.
• Isto Biologics Inc.
• OrthoTrophix LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 軟骨変性市場2029：新たな機会を提供する国
• 軟骨変性市場2029：新たな機会を提供するセグメント
• 軟骨変性市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cartilage degeneration refers to the progressive deterioration or breakdown of cartilage, a smooth and flexible connective tissue that covers the ends of bones in joints. This tissue acts as a cushion, enabling smooth joint movement by minimizing friction between bones. The degeneration of cartilage can result in pain, stiffness, and reduced joint functionality.

Common procedures to address cartilage degeneration include joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, and autologous chondrocyte implantation. Joint replacements involve surgically replacing a damaged or diseased joint with an artificial prosthesis. These procedures are applied to various joints such as the knee and hip and are performed in settings like hospitals, specialty clinics, ambulatory surgical centers, and academic or research institutes.

The cartilage degeneration market research report is one of a series of new reports from The Business Research Company that provides cartilage degeneration market statistics, including cartilage degeneration industry global market size, regional shares, competitors with a cartilage degeneration market share, detailed cartilage degeneration market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage degeneration industry. This cartilage degeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cartilage degeneration market size has grown strongly in recent years. It will grow from $12.63 billion in 2024 to $13.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.

The cartilage degeneration market size is expected to see strong growth in the next few years. It will grow to $16.62 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to regenerative medicine advancements, biologic injections, tissue engineering solutions, precision medicine, robotics-assisted surgery. Major trends in the forecast period include stem cell therapies, 3D printing in orthopedics, gene therapy for cartilage repair, personalized rehabilitation programs, telemedicine for follow-up care.

The rising prevalence of obesity is expected to drive the growth of the cartilage degeneration market in the coming years. Obesity, a condition characterized by excessive body fat accumulation, poses significant health risks. It contributes to cartilage degeneration by increasing compressive forces on cartilage and promoting inflammatory cytokines. This condition leads to several pathological changes in the knee joint, such as abnormal joint loading, misalignment, and muscle weakness. For example, data from the Government Digital Service in the UK revealed that in 2021-2022, 63.8% of adults aged 18 and older were classified as overweight or obese, up from 63.3% the previous year. Additionally, the obesity rate among adults increased from 25.2% in 2020-2021 to 25.9%. These statistics highlight the growing impact of obesity, which is fueling the expansion of the cartilage degeneration market.

The growth of the cartilage degeneration market is also being propelled by the increasing elderly population. Individuals aged 65 and older experience muscle and bone mass loss, leading to reduced strength and joint functionality. Cartilage degeneration treatments play a vital role in mitigating age-related changes in the musculoskeletal system, strengthening bones, and slowing bone loss. According to the World Health Organization (WHO), the global population aged 60 and older is projected to rise from 1 billion in 2020 to 1.4 billion by 2030, and 2.1 billion by 2050. Furthermore, the population aged 80 and older is expected to triple from 143 million in 2020 to 426 million by 2050. This demographic trend is a key driver of the cartilage degeneration market.

Leading companies in the cartilage degeneration market are innovating products to enhance cartilage repair and regeneration. One such product is Agili-C, a cell-free implant used to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints. In July 2023, CartiHeal Ltd., an Israeli medical device company, announced the first commercial implantation of Agili-C. Made from natural calcium carbonate derived from coral exoskeletons, the implant stimulates chondrocyte migration and extracellular matrix deposition. This design promotes natural cartilage and bone regeneration without relying on cells or growth factors. The implant's approval reinforces its safety and efficacy, benefiting patients and healthcare providers.

Companies in the cartilage degeneration market are increasingly focusing on regenerative therapies to strengthen their market positions. These therapies leverage advanced biological methods to restore damaged cartilage, promoting natural healing. For instance, in 2023, Zimmer Biomet, a U.S.-based medical device company, introduced its Tissue Regeneration System. This system employs proprietary scaffold technology made of biocompatible materials to support cartilage repair. It also offers customizable options to meet individual patient needs, improving healing outcomes and recovery times. Such innovations highlight a shift toward personalized medicine, addressing osteoarthritis and sports injuries while enhancing patient satisfaction.

In July 2022, Bioventus Inc., a U.S.-based company specializing in active healing and surgical orthobiologics, acquired CartiHeal for $315 million. This acquisition aims to bolster Bioventus' joint preservation technologies, contributing to its growth strategy and supporting its goal of sustained double-digit revenue growth. CartiHeal Ltd. develops proprietary implants for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, further enriching Bioventus' portfolio.

Major companies operating in the cartilage degeneration market report are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew PLC, B Braun Melsungen AG, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions PLC, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd.

North America was the largest region in the cartilage degeneration market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cartilage degeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cartilage degeneration market consists of revenues earned by entities by provide services such as diagnosis and evaluation, non-surgical management, patient education, physical therapy, and nutritional and lifestyle guidance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage degeneration market also includes sales of over-the-counter medications, joint supplements, topical pain relievers, and hyaluronic acid injections. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cartilage Degeneration Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cartilage degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cartilage degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cartilage degeneration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Procedure: Joint Replacements; Chondroplasty; Osteochondral Transplants; Microfracture; Meniscus Transplants; Cell-Based Cartilage Resurfacing; Autologous Chondrocyte Implantation; Other Procedures
• 2) By Application: Knee; Hip; Other Applications
• 3) By End User: Hospitals And Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes
• Subsegments:
• 1) By Joint Replacements: Knee Replacement (Partial, Total); Hip Replacement (Partial, Total); Shoulder Replacement (Total, Reverse); Other Joints (Ankle, Elbow, Wrist)
• 2) By Chondroplasty: Radiofrequency Ablation Chondroplasty; Mechanical Chondroplasty; Thermal Chondroplasty; Arthroscopic Chondroplasty
• 3) By Osteochondral Transplants: Autografts (OATS); Allografts (Fresh Osteochondral Allografts); Synthetic Implants
• 4) By Microfracture: Traditional Microfracture; Augmented Microfracture (with scaffolds or matrix implants)
• 5) By Meniscus Transplants: Allograft Meniscus Transplantation (Cryopreserved, Fresh Frozen); Synthetic Meniscus Implants
• 6) By Cell-Based Cartilage Resurfacing: Autologous Cell-Based Therapy; Allogeneic Cell-Based Therapy; Stem Cell-Based Cartilage Repair
• 7) By Autologous Chondrocyte Implantation (ACI): First-Generation ACI; Second-Generation ACI; Third-Generation ACI (MACI)
• 8) By Other Procedures: Arthroscopic Debridement; Osteotomy; Cartilage Repair Using Synthetic Scaffolds; Injection-Based Therapies (Hyaluronic Acid, PRP, Stem Cell Injections)
• Companies Mentioned: Johnson & Johnson Services Inc.; MEDIPOST Co. Ltd.; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cartilage Degeneration Market Characteristics

3. Cartilage Degeneration Market Trends And Strategies

4. Cartilage Degeneration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cartilage Degeneration Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cartilage Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cartilage Degeneration Market Growth Rate Analysis
• 5.4. Global Cartilage Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cartilage Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cartilage Degeneration Total Addressable Market (TAM)

6. Cartilage Degeneration Market Segmentation

• 6.1. Global Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Joint Replacements
• Chondroplasty
• Osteochondral Transplants
• Microfracture
• Meniscus Transplants
• Cell-Based Cartilage Resurfacing
• Autologous
• 6.2. Global Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Knee
• Hip
• Other Applications
• 6.3. Global Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Specialty Clinics
• Ambulatory Surgical Centers
• Academic And Research Institutes
• 6.4. Global Cartilage Degeneration Market, Sub-Segmentation Of Joint Replacements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Knee Replacement (Partial, Total)
• Hip Replacement (Partial, Total)
• Shoulder Replacement (Total, Reverse)
• Other Joints (Ankle, Elbow, Wrist)
• 6.5. Global Cartilage Degeneration Market, Sub-Segmentation Of Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation Chondroplasty
• Mechanical Chondroplasty
• Thermal Chondroplasty
• Arthroscopic Chondroplasty
• 6.6. Global Cartilage Degeneration Market, Sub-Segmentation Of Osteochondral Transplants, B Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autografts (OATS)
• Allografts (Fresh Osteochondral Allografts)
• Synthetic Implants
• 6.7. Global Cartilage Degeneration Market, Sub-Segmentation Of Microfracture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Microfracture
• Augmented Microfracture
• 6.8. Global Cartilage Degeneration Market, Sub-Segmentation Of Meniscus Transplants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allograft Meniscus Transplantation
• Synthetic Meniscus Implants
• 6.9. Global Cartilage Degeneration Market, Sub-Segmentation Of Cell-Based Cartilage Resurfacing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Cell-Based Therapy
• Allogeneic Cell-Based Therapy
• Stem Cell-Based Cartilage Repair
• 6.10. Global Cartilage Degeneration Market, Sub-Segmentation Of Autologous Chondrocyte Implantation (ACI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation ACI
• Second-Generation ACI
• Third-Generation ACI (MACI)
• 6.11. Global Cartilage Degeneration Market, Sub-Segmentation Of Other Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arthroscopic Debridement
• Osteotomy
• Cartilage Repair Using Synthetic Scaffolds
• Injection-Based Therapies

7. Cartilage Degeneration Market Regional And Country Analysis

• 7.1. Global Cartilage Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cartilage Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cartilage Degeneration Market

• 8.1. Asia-Pacific Cartilage Degeneration Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cartilage Degeneration Market

• 9.1. China Cartilage Degeneration Market Overview
• 9.2. China Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cartilage Degeneration Market

• 10.1. India Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cartilage Degeneration Market

• 11.1. Japan Cartilage Degeneration Market Overview
• 11.2. Japan Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cartilage Degeneration Market

• 12.1. Australia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cartilage Degeneration Market

• 13.1. Indonesia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cartilage Degeneration Market

• 14.1. South Korea Cartilage Degeneration Market Overview
• 14.2. South Korea Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cartilage Degeneration Market

• 15.1. Western Europe Cartilage Degeneration Market Overview
• 15.2. Western Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cartilage Degeneration Market

• 16.1. UK Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cartilage Degeneration Market

• 17.1. Germany Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cartilage Degeneration Market

• 18.1. France Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cartilage Degeneration Market

• 19.1. Italy Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cartilage Degeneration Market

• 20.1. Spain Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cartilage Degeneration Market

• 21.1. Eastern Europe Cartilage Degeneration Market Overview
• 21.2. Eastern Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cartilage Degeneration Market

• 22.1. Russia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cartilage Degeneration Market

• 23.1. North America Cartilage Degeneration Market Overview
• 23.2. North America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cartilage Degeneration Market

• 24.1. USA Cartilage Degeneration Market Overview
• 24.2. USA Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cartilage Degeneration Market

• 25.1. Canada Cartilage Degeneration Market Overview
• 25.2. Canada Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cartilage Degeneration Market

• 26.1. South America Cartilage Degeneration Market Overview
• 26.2. South America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cartilage Degeneration Market

• 27.1. Brazil Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cartilage Degeneration Market

• 28.1. Middle East Cartilage Degeneration Market Overview
• 28.2. Middle East Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cartilage Degeneration Market

• 29.1. Africa Cartilage Degeneration Market Overview
• 29.2. Africa Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cartilage Degeneration Market Competitive Landscape And Company Profiles

• 30.1. Cartilage Degeneration Market Competitive Landscape
• 30.2. Cartilage Degeneration Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. MEDIPOST Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cartilage Degeneration Market Other Major And Innovative Companies

• 31.1. Smith and Nephew plc
• 31.2. B Braun Melsungen AG
• 31.3. Osiris Therapeutics Inc.
• 31.4. Arthrex Inc.
• 31.5. Conmed Corporation
• 31.6. Orthocell Ltd.
• 31.7. Bioventus LLC
• 31.8. Aesculap Inc.
• 31.9. Vericel Corporation
• 31.10. Anika Therapeutics Inc.
• 31.11. Geistlich Pharma AG
• 31.12. MatTek Corporation
• 31.13. Breg Inc.
• 31.14. Isto Biologics Inc.
• 31.15. OrthoTrophix LLC

32. Global Cartilage Degeneration Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cartilage Degeneration Market

34. Recent Developments In The Cartilage Degeneration Market

35. Cartilage Degeneration Market High Potential Countries, Segments and Strategies

• 35.1 Cartilage Degeneration Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cartilage Degeneration Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cartilage Degeneration Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer